Market Cap 118.20M
Revenue (ttm) 1.55M
Net Income (ttm) -63.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,068.39%
Debt to Equity Ratio 0.00
Volume 1,947,400
Avg Vol 1,508,022
Day's Range N/A - N/A
Shares Out 124.50M
Stochastic %K 8%
Beta 0.98
Analysts Strong Sell
Price Target $5.86

Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a...

Industry: Biotechnology
Sector: Healthcare
Phone: 514 336 0444
Address:
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, Canada
647ngocnu
647ngocnu Sep. 16 at 2:14 AM
$MIST very positive thank you for information
0 · Reply
Bio_Invest101
Bio_Invest101 Sep. 16 at 1:25 AM
$NUVB $MIST $ARDX $IRWD Here’re the predictions by JPM for Fed day tomorrow. It’s been a rough few days for many investors. Hope Warsh delivers the good news. Prayer
0 · Reply
CashisKing_
CashisKing_ Sep. 15 at 11:17 PM
$MIST a lot of bulls out today and new buyers! Welcome 🙏
0 · Reply
KilroyPicks
KilroyPicks Sep. 15 at 9:55 PM
$MIST - https://www.investing.com/news/transcripts/milestone-pharmaceuticals-at-hc-wainwright-launch-gains-and-afib-push-93CH-4902203
1 · Reply
cubsoxbull
cubsoxbull Sep. 15 at 8:37 PM
$MIST Interesting, was watching the close, went to 0.94 and then less than a second later, boom down to 0.9277 for the close. Guess someone is playing games to keep this down.
1 · Reply
Carnut68
Carnut68 Sep. 15 at 6:29 PM
$MIST no offense badger but this made me chuckle. it took those to fireside chats to make you believe that sales and margins will be improving over the next 12 months? It’s a new drug ffs, starting from essentially zero sales and no insurance coverage so, yeah, sales and margins are gonna improve over the next year. They can’t go down. Welcome aboard.
1 · Reply
Badgerkid
Badgerkid Sep. 15 at 5:16 PM
$MIST Wells Fargo 21st Annual Healthcare Conference Format: Fireside chat and 1x1s Presentation Date: September 8, 2026 Time: 1:30 pm ET Location: Boston, MA H.C. Wainwright 28th Annual Global Investment Conference Format: Fireside chat and 1x1s Presentation Date: September 15, 2026 Time: 10:30 am ET Location: New York, NY Milestone seems to be reasonably positioned for nice future growth at this time. It seems like a good time to start building a position. Always do your own due diligence. https://investors.milestonepharma.com/news-releases/news-release-details/milestone-pharmaceuticals-present-upcoming-investor-6
0 · Reply
Badgerkid
Badgerkid Sep. 15 at 5:16 PM
$MIST I typically don't post on any boards for my more speculative investments. You'll find me posting on the IOVA board, my primary long investment, but I'm here to say that I'm finally adding back a few shares in MIST. I don't think Milestone is out of the woods yet, but those two recent chats have me believing that Milestone is on its way to improving sales and rev growth over the next 12 months. Seems like a good time to nibble just a bit and pick up a few shares in this seemingly oversold price range. Sub $1 seems cheap, but MIST is not without its risk. Do your due diligence - know your risk tolerance. I'm not here to recommend this stock to anyone who hasn't done their homework. I've been following this company for several years and made a few small trades over the past couple of years. Now I'm thinking I'd like to build and hold for a while this time around. I like their product, but let's see if they can get the necessary market penetration GL MIST longs.
2 · Reply
Diverstj981
Diverstj981 Sep. 15 at 5:06 PM
$MIST We just hit 8k watchers and some buyers seem to be stepping in at these prices on low avg vol.
0 · Reply
cubsoxbull
cubsoxbull Sep. 15 at 3:54 PM
$MIST Well bought , 5000 more for me this morning and 3000 more for the wife.
2 · Reply
Latest News on MIST
Milestone Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 4 weeks ago

Milestone Pharmaceuticals Earnings Call Transcript: Q2 2026


Milestone Pharmaceuticals Quarterly report: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 4 weeks ago

Milestone Pharmaceuticals Quarterly report: Q2 2026


Milestone Pharmaceuticals Earnings release: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 4 weeks ago

Milestone Pharmaceuticals Earnings release: Q2 2026


Milestone Pharmaceuticals Registration statement: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 4 weeks ago

Milestone Pharmaceuticals Registration statement: Q2 2026


Milestone Pharmaceuticals Registration statement: Q2 2026

Aug 12, 2026, 8:30 AM EDT - 4 weeks ago

Milestone Pharmaceuticals Registration statement: Q2 2026


Milestone Pharmaceuticals Slides: Corporate presentation

Aug 12, 2026, 8:00 AM EDT - 4 weeks ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals Slides: Corporate presentation

Jun 1, 2026, 7:00 AM EDT - 3 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals files $300M mixed securities shelf

2026-05-13T21:54:39.000Z - 4 months ago

Milestone Pharmaceuticals files $300M mixed securities shelf


Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c

2026-05-13T12:41:15.000Z - 4 months ago

Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c


Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026


Milestone Pharmaceuticals Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Quarterly report: Q1 2026


Milestone Pharmaceuticals Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Earnings release: Q1 2026


Milestone Pharmaceuticals Registration statement: Q1 2026

May 13, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Registration statement: Q1 2026


Milestone Pharmaceuticals Registration statement: Q1 2026

May 13, 2026, 8:30 AM EDT - 4 months ago

Milestone Pharmaceuticals Registration statement: Q1 2026


Milestone Pharmaceuticals Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 4 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Milestone Pharmaceuticals Proxy statement: Proxy filing


Milestone Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Milestone Pharmaceuticals Proxy statement: Proxy filing


Milestone Pharmaceuticals Slides: Corporate presentation

Apr 14, 2026, 7:00 AM EDT - 5 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals provides details on RESET-PSVT trial

2026-04-10T12:06:08.000Z - 5 months ago

Milestone Pharmaceuticals provides details on RESET-PSVT trial


Milestone Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 5 months ago

Milestone Pharmaceuticals Earnings Call Transcript: Q4 2025


Milestone Pharmaceuticals Earnings release: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 5 months ago

Milestone Pharmaceuticals Earnings release: Q4 2025


Milestone Pharmaceuticals Annual report: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 5 months ago

Milestone Pharmaceuticals Annual report: Q4 2025


Milestone Pharmaceuticals Registration statement: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 5 months ago

Milestone Pharmaceuticals Registration statement: Q4 2025


Milestone Pharmaceuticals Registration statement: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 5 months ago

Milestone Pharmaceuticals Registration statement: Q4 2025


Milestone Pharmaceuticals reports Q4 EPS (16c), consensus (18c)

2026-03-20T11:21:41.000Z - 5 months ago

Milestone Pharmaceuticals reports Q4 EPS (16c), consensus (18c)


Milestone Pharmaceuticals to present Cardamyst data at ACC 26

2026-03-16T12:23:37.000Z - 6 months ago

Milestone Pharmaceuticals to present Cardamyst data at ACC 26


Milestone Pharmaceuticals Slides: Corporate presentation

Feb 6, 2026, 7:00 AM EST - 7 months ago

Milestone Pharmaceuticals Slides: Corporate presentation


Milestone Pharmaceuticals Transcript: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 9 months ago

Milestone Pharmaceuticals Transcript: FDA Announcement


Milestone Pharmaceuticals Press release: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 9 months ago

Milestone Pharmaceuticals Press release: FDA Announcement


Milestone Pharmaceuticals Slides: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 9 months ago

Milestone Pharmaceuticals Slides: FDA Announcement


Milestone Pharmaceuticals Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Milestone Pharmaceuticals Earnings release: Q3 2025


Milestone Pharmaceuticals Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Milestone Pharmaceuticals Quarterly report: Q3 2025


Milestone Pharmaceuticals Registration statement: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Milestone Pharmaceuticals Registration statement: Q3 2025


Milestone Pharmaceuticals Registration statement: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

Milestone Pharmaceuticals Registration statement: Q3 2025


Milestone Pharmaceuticals Slides: Company Presentation

Nov 12, 2025, 7:00 AM EST - 10 months ago

Milestone Pharmaceuticals Slides: Company Presentation


Milestone Pharmaceuticals Earnings release: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Earnings release: Q2 2025


Milestone Pharmaceuticals Quarterly report: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Quarterly report: Q2 2025


Milestone Pharmaceuticals Registration statement: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Registration statement: Q2 2025


Milestone Pharmaceuticals Registration statement: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Registration statement: Q2 2025


Milestone Pharmaceuticals Announces Proposed Public Offering

Jul 11, 2025, 6:01 AM EDT - 1 year ago

Milestone Pharmaceuticals Announces Proposed Public Offering


Milestone Pharmaceuticals Earnings release: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Earnings release: Q1 2025


Milestone Pharmaceuticals Quarterly report: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Quarterly report: Q1 2025


Milestone Pharmaceuticals Registration statement: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Registration statement: Q1 2025


Milestone Pharmaceuticals Registration statement: Q1 2025

May 14, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Registration statement: Q1 2025


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 1 year ago

FDA Issues Complete Response Letter for Etripamil for PSVT


Milestone Pharmaceuticals Annual report: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Annual report: Q4 2024


Milestone Pharmaceuticals Earnings release: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Earnings release: Q4 2024


Milestone Pharmaceuticals Registration statement: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Registration statement: Q4 2024


Milestone Pharmaceuticals Registration statement: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Milestone Pharmaceuticals Registration statement: Q4 2024


Milestone Pharmaceuticals Transcript: Investor update

Feb 25, 2025, 10:30 AM EST - 1 year ago

Milestone Pharmaceuticals Transcript: Investor update


Milestone Pharmaceuticals Slides: Investor update

Feb 25, 2025, 10:30 AM EST - 1 year ago

Milestone Pharmaceuticals Slides: Investor update


Milestone Pharmaceuticals Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Milestone Pharmaceuticals Earnings release: Q3 2024


Milestone Pharmaceuticals Registration statement: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Milestone Pharmaceuticals Registration statement: Q3 2024


Milestone Pharmaceuticals Registration statement: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Milestone Pharmaceuticals Registration statement: Q3 2024


Milestone Pharmaceuticals Slides: Corporate Presentation

Nov 12, 2024, 8:00 AM EST - 1 year ago

Milestone Pharmaceuticals Slides: Corporate Presentation


Milestone Pharmaceuticals Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Earnings release: Q2 2024


Milestone Pharmaceuticals Registration statement: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Registration statement: Q2 2024


Milestone Pharmaceuticals Registration statement: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Registration statement: Q2 2024


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Proxy statement: Proxy Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Proxy statement: Proxy Filing


Milestone Pharmaceuticals Transcript: Study update

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Transcript: Study update


Milestone Pharmaceuticals Earnings release: Q1 2024

May 13, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Earnings release: Q1 2024


Milestone Pharmaceuticals Registration statement: Q1 2024

May 13, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Registration statement: Q1 2024


Milestone Pharmaceuticals Registration statement: Q1 2024

May 13, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Registration statement: Q1 2024


647ngocnu
647ngocnu Sep. 16 at 2:14 AM
$MIST very positive thank you for information
0 · Reply
Bio_Invest101
Bio_Invest101 Sep. 16 at 1:25 AM
$NUVB $MIST $ARDX $IRWD Here’re the predictions by JPM for Fed day tomorrow. It’s been a rough few days for many investors. Hope Warsh delivers the good news. Prayer
0 · Reply
CashisKing_
CashisKing_ Sep. 15 at 11:17 PM
$MIST a lot of bulls out today and new buyers! Welcome 🙏
0 · Reply
KilroyPicks
KilroyPicks Sep. 15 at 9:55 PM
$MIST - https://www.investing.com/news/transcripts/milestone-pharmaceuticals-at-hc-wainwright-launch-gains-and-afib-push-93CH-4902203
1 · Reply
cubsoxbull
cubsoxbull Sep. 15 at 8:37 PM
$MIST Interesting, was watching the close, went to 0.94 and then less than a second later, boom down to 0.9277 for the close. Guess someone is playing games to keep this down.
1 · Reply
Carnut68
Carnut68 Sep. 15 at 6:29 PM
$MIST no offense badger but this made me chuckle. it took those to fireside chats to make you believe that sales and margins will be improving over the next 12 months? It’s a new drug ffs, starting from essentially zero sales and no insurance coverage so, yeah, sales and margins are gonna improve over the next year. They can’t go down. Welcome aboard.
1 · Reply
Badgerkid
Badgerkid Sep. 15 at 5:16 PM
$MIST Wells Fargo 21st Annual Healthcare Conference Format: Fireside chat and 1x1s Presentation Date: September 8, 2026 Time: 1:30 pm ET Location: Boston, MA H.C. Wainwright 28th Annual Global Investment Conference Format: Fireside chat and 1x1s Presentation Date: September 15, 2026 Time: 10:30 am ET Location: New York, NY Milestone seems to be reasonably positioned for nice future growth at this time. It seems like a good time to start building a position. Always do your own due diligence. https://investors.milestonepharma.com/news-releases/news-release-details/milestone-pharmaceuticals-present-upcoming-investor-6
0 · Reply
Badgerkid
Badgerkid Sep. 15 at 5:16 PM
$MIST I typically don't post on any boards for my more speculative investments. You'll find me posting on the IOVA board, my primary long investment, but I'm here to say that I'm finally adding back a few shares in MIST. I don't think Milestone is out of the woods yet, but those two recent chats have me believing that Milestone is on its way to improving sales and rev growth over the next 12 months. Seems like a good time to nibble just a bit and pick up a few shares in this seemingly oversold price range. Sub $1 seems cheap, but MIST is not without its risk. Do your due diligence - know your risk tolerance. I'm not here to recommend this stock to anyone who hasn't done their homework. I've been following this company for several years and made a few small trades over the past couple of years. Now I'm thinking I'd like to build and hold for a while this time around. I like their product, but let's see if they can get the necessary market penetration GL MIST longs.
2 · Reply
Diverstj981
Diverstj981 Sep. 15 at 5:06 PM
$MIST We just hit 8k watchers and some buyers seem to be stepping in at these prices on low avg vol.
0 · Reply
cubsoxbull
cubsoxbull Sep. 15 at 3:54 PM
$MIST Well bought , 5000 more for me this morning and 3000 more for the wife.
2 · Reply
BigFishLittleCompany
BigFishLittleCompany Sep. 15 at 3:51 PM
$MIST this is so oversold. Very obvious overreaction by the market. A 14 day RSI of roughly 12.
0 · Reply
soccerfan913
soccerfan913 Sep. 15 at 3:46 PM
$MIST Fuck me, the market certainly responds when these guys talk. Some numpty on yahoo claimed the bottom again this morning. How many times?
3 · Reply
CookieTC
CookieTC Sep. 15 at 3:45 PM
$MIST I invested in this awhile ago because I did have afib and would’ve purchased this in a heartbeat to keep me out of the ER constantly before they finally gave me a cardiac ablation. So I’m so confused why this is failing and shorted so bad. What does the public not know about why this failed
0 · Reply
Gosha69
Gosha69 Sep. 15 at 3:40 PM
$MIST $0.50 inbound. Management has likely seen sales numbers and is dumping into this. $MIST management crooks should be in jail
0 · Reply
Lucas_F
Lucas_F Sep. 15 at 3:34 PM
$MIST 🙌🏽
0 · Reply
JanetBSmellin
JanetBSmellin Sep. 15 at 3:29 PM
$MIST LABU, XBI, and all indexes are down big. I’m taking this time to add.
2 · Reply
Pdxlife01
Pdxlife01 Sep. 15 at 3:08 PM
$MIST mind blown! good news after good news and presentation was positive and encouraging but yet it still keeps falling! devastation!!
2 · Reply
doctorhak
doctorhak Sep. 15 at 3:03 PM
$MIST Indeed. EPs will lead the way and Cardiologists will follow. From 303, estimated 20% have concomitant Afib+RVR. It’s safe; Wait for it Guideline Directed medical therapy adoption is coming and PIP will be dropped for PSVT. Prescribe PIP at your own risk
2 · Reply
Pszemsss
Pszemsss Sep. 15 at 3:01 PM
$MIST any transcription?
0 · Reply
Acemaker12
Acemaker12 Sep. 15 at 2:52 PM
$MIST good presentation this morning
0 · Reply
Tilbury100
Tilbury100 Sep. 15 at 2:51 PM
$MIST all sounded positive to me
0 · Reply
JanetBSmellin
JanetBSmellin Sep. 15 at 2:38 PM
$MIST Enjoying this conference thus far. 👍
0 · Reply